Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis

• Nora Liebers,
• Stefan O. Schönland,
• Claudius Speer,
• Dominic Edelmann,
• Paul Schnitzler,
• Hans-Georg Kräusslich,
• Carsten Mueller-Tidow,
• Ute Hegenbart,
• Sascha Dietrich

Affiliations

Nora Liebers

1 Department of Medicine V, Heidelberg University Hospital, Germany

Stefan O. Schönland

1 Department of Medicine V, Heidelberg University Hospital, Germany

Claudius Speer

3 Department of Nephrology, Heidelberg University Hospital, Germany

Dominic Edelmann

4 German Cancer Research Center, Division of Biostatistics, Heidelberg, Germany

Paul Schnitzler

5 Department of Infectious Diseases, Virology, Heidelberg University Hospital, Germany

Hans-Georg Kräusslich

5 Department of Infectious Diseases, Virology, Heidelberg University Hospital, Germany

Carsten Mueller-Tidow

1 Department of Medicine V, Heidelberg University Hospital, Germany

Ute Hegenbart

1 Department of Medicine V, Heidelberg University Hospital, Germany

Sascha Dietrich

1 Department of Medicine V, Heidelberg University Hospital, Germany